Medical & healthcare apps of Atypical Antipsychotics are listed with us

Atypical Antipsychotics

The atypical antipsychotics (AAP) (also known as second generation antipsychotics (SGAs)) are a group of antipsychotic drugs (antipsychotic drugs in general are also known as major tranquilisers and neuroleptics although the latter is usually reserved for the typical antipsychotics) used to treat psychiatric conditions. Some atypical antipsychotics have received regulatory approval (e.g. by the FDA of the US, the TGA of Australia, the MHRA of the UK) for schizophrenia, bipolar disorder, autism and as an adjunct in major depressive disorder.